HALO
Halozyme Therape (HALO)
NASDAQ
$100.95-$0.73 (-0.72%)
Price as of Nov 12, 2026 9:34 AM EST
  • $11.6B
    Market Cap
  • 43.96%
    1-Year Change
  • Biotechnology
    Industry
HALO
vs History
vs S&P 500
General Statistics
Latest Close
$101.68
Change
-$1.30 (-1.26%)
Open
$101.26
High
$102.62
Low
$99.27
Previous Close
$102.98
Volume
2,505,104
30-Day Average Volume
2,412,701
1-Week Change
-21.99%
1-Month Change
-7.92%
1-Year Change
43.96%
3-Year Change
172.97%
5-Year Change
163.62%
Fundamentals
Shares Outstanding
114.0M
Total Assets
$3.5B
Market Cap
$11.6B
Enterprise Value
$13.8B
Period:
QTR
TTM
FY
Revenue
$341.0M
Net Income
$247.0M
Free Cash Flow
$255.2M
EBIT
$290.9M
EBITDA
$320.4M
Net Working Capital
$1.4B
EPS
$2.01
Enterprise Value/EBITDA
43
Enterprise Value/Revenue
41
P/B
-210
P/E
51
PEG
9
Price/Free Cash Flow
45
Price/Operating Cash Flow
45
Dividends & Splits
Forward Annual Dividend Yield
N/A
Trailing Annual Dividend Yield
N/A
Ex-Dividend Date
N/A
Last Split Factor
N/A
Last Split Date
N/A

Earnings & Revenue